aTyr Pharma, Inc. total revenue, net income and dynamics of changes in US dollar today
aTyr Pharma, Inc. net revenue for today is 0 $. Net income aTyr Pharma, Inc. - -7 151 000 $. Information about net income is used from open sources. Here are the main financial indicators of aTyr Pharma, Inc.. The financial report chart on our website displays information by dates from 30/06/2017 to 31/03/2021. The financial report on the chart of aTyr Pharma, Inc. allows you to clearly see the dynamics of fixed assets. All information on aTyr Pharma, Inc. total revenue on this chart is created in the form of yellow bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
0 $
-
-7 151 000 $
-
31/12/2020
2 053 000 $
-
-4 932 000 $
-
30/09/2020
148 000 $
-19.565 % ↓
-6 599 000 $
-
30/06/2020
189 000 $
+101.06 % ↑
-6 446 000 $
-
30/09/2019
184 000 $
-
-5 645 000 $
-
30/06/2019
94 000 $
-
-5 848 000 $
-
31/03/2019
0 $
-
-6 137 000 $
-
31/12/2018
0 $
-
-6 322 000 $
-
30/09/2018
0 $
-
-7 114 000 $
-
30/06/2018
0 $
-
-10 412 000 $
-
31/03/2018
0 $
-
-10 667 000 $
-
31/12/2017
0 $
-
-11 474 000 $
-
30/09/2017
0 $
-
-11 190 000 $
-
30/06/2017
0 $
-
-12 138 000 $
-
Show:
to
aTyr Pharma, Inc. financial report charts
Dates of aTyr Pharma, Inc. finance reports: 30/06/2017, 31/12/2020, 31/03/2021. The dates of financial statements are strictly regulated by law and financial statements. The current date of the financial report of aTyr Pharma, Inc. for today is 31/03/2021. Gross profit aTyr Pharma, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit aTyr Pharma, Inc. is -4 516 000 $
aTyr Pharma, Inc. quarterly report dates
Cost of revenue aTyr Pharma, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue aTyr Pharma, Inc. is 4 516 000 $ Operating income aTyr Pharma, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income aTyr Pharma, Inc. is -7 202 000 $ Net income aTyr Pharma, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income aTyr Pharma, Inc. is -7 151 000 $
Current assets aTyr Pharma, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets aTyr Pharma, Inc. is 52 134 000 $ Total assets aTyr Pharma, Inc. refers to the total amount of assets owned by a person or entity. Total assets aTyr Pharma, Inc. is 55 128 000 $ Current cash aTyr Pharma, Inc. - the sum of all of the cash a company has on the date of report. Current cash aTyr Pharma, Inc. is 12 587 000 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
30/09/2019
30/06/2019
31/03/2019
31/12/2018
30/09/2018
30/06/2018
31/03/2018
31/12/2017
30/09/2017
30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-4 516 000 $
-2 645 000 $
-4 468 000 $
-4 172 000 $
-3 615 000 $
-3 220 000 $
-
-
-
-
-
-
-
-
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
4 516 000 $
4 698 000 $
4 616 000 $
4 361 000 $
3 799 000 $
3 314 000 $
-
-
-
-
-
-
-
-
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
-
2 053 000 $
148 000 $
189 000 $
184 000 $
94 000 $
-
-
-
-
-
-
-
-
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
184 000 $
94 000 $
-
-
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-7 202 000 $
-4 940 000 $
-6 512 000 $
-6 318 000 $
-5 498 000 $
-5 641 000 $
-5 877 000 $
-6 363 000 $
-6 677 000 $
-8 660 000 $
-10 220 000 $
-11 200 000 $
-10 827 000 $
-11 907 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-7 151 000 $
-4 932 000 $
-6 599 000 $
-6 446 000 $
-5 645 000 $
-5 848 000 $
-6 137 000 $
-6 322 000 $
-7 114 000 $
-10 412 000 $
-10 667 000 $
-11 474 000 $
-11 190 000 $
-12 138 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
-
-
-
-
3 799 000 $
3 799 000 $
3 345 000 $
3 849 000 $
4 202 000 $
5 584 000 $
6 150 000 $
5 310 000 $
7 133 000 $
8 420 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
7 202 000 $
6 993 000 $
6 660 000 $
6 507 000 $
5 682 000 $
5 735 000 $
5 877 000 $
6 363 000 $
6 677 000 $
8 660 000 $
10 220 000 $
11 200 000 $
10 827 000 $
11 907 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
52 134 000 $
35 531 000 $
38 218 000 $
43 840 000 $
39 144 000 $
43 871 000 $
44 744 000 $
50 803 000 $
57 645 000 $
65 997 000 $
76 006 000 $
86 985 000 $
92 206 000 $
59 098 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
55 128 000 $
38 726 000 $
41 636 000 $
47 562 000 $
43 745 000 $
48 762 000 $
49 915 000 $
52 746 000 $
59 774 000 $
68 308 000 $
78 470 000 $
89 355 000 $
94 487 000 $
61 472 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
12 587 000 $
16 952 000 $
18 151 000 $
21 632 000 $
17 341 000 $
14 507 000 $
12 965 000 $
22 962 000 $
31 547 000 $
19 272 000 $
21 936 000 $
21 091 000 $
29 765 000 $
35 915 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
11 828 000 $
11 304 000 $
11 175 000 $
10 833 000 $
10 723 000 $
11 084 000 $
7 027 000 $
5 012 000 $
2 267 000 $
2 786 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
-
-
74 100 000 $
85 119 000 $
90 381 000 $
57 221 000 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
17 009 000 $
18 536 000 $
20 430 000 $
19 096 000 $
20 788 000 $
22 932 000 $
19 977 000 $
19 731 000 $
14 746 000 $
14 578 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
38.88 %
38.01 %
40.93 %
36.20 %
34.78 %
33.57 %
25.46 %
22.08 %
15.61 %
23.71 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
49 702 000 $
31 650 000 $
32 161 000 $
36 100 000 $
26 734 000 $
30 224 000 $
29 483 000 $
33 648 000 $
38 984 000 $
45 374 000 $
54 498 000 $
64 245 000 $
72 288 000 $
40 031 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-4 253 000 $
-4 821 000 $
-6 023 000 $
-4 839 000 $
-6 460 000 $
-9 187 000 $
-10 577 000 $
-10 306 000 $
-8 894 000 $
-9 276 000 $
Last revenue report of aTyr Pharma, Inc. was 31/03/2021. According to last financial report total revenue in aTyr Pharma, Inc. was 0 US dollar and changed by -19.565% since last year. Net income in aTyr Pharma, Inc. was -7 151 000 $ in last quartal, net income changes to 0%.
aTyr Pharma, Inc. stocks data
LIFE stock price
aTyr Pharma, Inc. stock price today, LIFE stock quote.
